Sarah Ketterer’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$229K Buy
+3,673
New +$232K ﹤0.01% 111
2024
Q4
– Sell
-750,455
Closed -$38.8M – 109
2024
Q3
$38.8M Buy
750,455
+23,103
+3% +$1.08M 0.95% 32
2024
Q2
$30.2M Buy
+727,352
New +$32.5M 0.82% 40

Other funds holding BMY

Sarah Ketterer's BMY Position: Q3 2026 in Review

Sarah Ketterer opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,673 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #111 among its holdings. This is a return to the name: Sarah Ketterer previously reported a position in BMY as recently as Q3 2024.

Sarah Ketterer first reported a position in BMY in Q2 2024 and has held it in 3 quarters since. The position peaked at $38.8M in Q3 2024. 2,566 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Sarah Ketterer held 3,673 shares of Bristol-Myers Squibb worth $229K as of Q3 2026.
  • Bristol-Myers Squibb was a new Sarah Ketterer position in Q3 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Sarah Ketterer's portfolio in Q3 2026, its #111 holding.
  • Sarah Ketterer first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 3 quarters since.
  • Sarah Ketterer's Bristol-Myers Squibb position peaked at $38.8M in Q3 2024.
  • 2,566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Causeway Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.